glp-1 neurotransmitter Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Frontiers | Mini Review: Effect

KPV plasma half-life: Approximately 10-15 minutes (small tripeptide)

For general information about semaglutide and weight management, the FDA and NIH are helpful references

Additionally, these drugs act on areas of the brain that regulate appetite and food intake, further promoting a reduction in calorie consumption

13 In the SURPASS-4 trial (phase III), participants taking tirzepatide showed a much lower occurrence of composite kidney endpoint (time to first occurrence of eGFR decline of at least 40% from baseline, end-stage kidney disease, death due to kidney failure, or new onset albuminuria) compared with those who received insulin glargine (HR 0.58)

Some studies indicate potential benefits for brain health as well